Pharmacogenetics—A Brief Overview

Weinshilboum RM . Human pharmacogenetics—introduction. Fed Proc 1984; 43: 2295–7.

Bloom KE Brewer GJ Magon AM Wetterstroem BS . Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency. Clin Pharmacol Ther 1983; 33: 403–9.

Spielberg SP . In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984; 43: 2308–13.

Basmajian JV , eds. Stedman's medical dictionary, 24th edition. Baltimore: Williams and Wilkins, 1982: 1119.

Eichelbaum M . Polymorphic drug oxidation in humans. Fed Proc 1984; 43: 2298–302.

Jim LK . Chapter 26. Adverse effects of drugs on the liver. In: Katcher BS Young LY Koda-Kimble MA , eds. Applied therapeutics—the clinical use of drugs. 3rd ed. San Francisco: Applied Therapeutics, Inc., 1983: 515–38.

Weber WW . Acetylation pharmacogenetics: Experimental models for human toxicity. Fed Proc 1984; 43: 2332–7.

O'Reilly RA Aggeler PM Hoag MS Leong LS . Hereditary transmission of exceptional resistance to coumarin anticoagulant drugs. The first reported kindred. N Engl J Med 1964; 271: 809.

Lewis RJ . Warfarin resistance. Am J Med 1967; 42: 620–4.

Mennear JH . Familial pharmacology. AFP 1977; 15: 100–2.

Petersdorf RG . Disturbances of heat regulation. In: Petersdorf RG Adams RD Braunwald E Isselbacher KJ Martin JB Wilson JD , eds. Harrison's principles of internal medicine. 10th ed. New York: McGraw-Hill, 1983: 50–7.

Korman NE . Anemias. In: Katcher BS Young LY Koda-Kimble MA , eds. Applied therapeutics—the clinical use of drugs. 3rd ed. San Francisco: Applied Therapeutics, Inc., 1983: 871–98.

Swanson M Cook R , eds. Drugs, chemicals and blood dyscrasias. Hamilton, IL: Drug Intelligence Publications, Inc., 1977: 820–33.